Phortas Members to Present at RAPS Euro Convergence 2024 in Berlin

We are delighted to announce that our two senior Phortas members will be presenting at RAPS Euro Convergence, scheduled from 06-08 May 2024 in Berlin.

Our Managing Director, Jasmina Savic, will lead a discussion on a crucial topic: "Meeting EMA and FDA: Formal and informal pathways, in search of alignment." This session promises to offer insights into essential strategies for harmonizing regulatory approaches between the European Medicines Agency (EMA) and the Food and Drug Administration (FDA). Joining Jasmina Savic will be the Head of Scientific Advice at the European Medicines Agency, providing valuable perspectives to the conversation.

Moreover, our Senior Regulatory Affairs Manager, Irena Milobratovic, will have a poster presentation on expedited drug development programs, and adequate regulatory strategies in the EU and FDA, addressing also a topic vital to the current regulatory environment in the EU – non-harmonization, and its impact to access to innovative therapies.

Phortas is honoured to contribute to the RAPS Euro Convergence 2024, and we eagerly anticipate sharing our expertise and fostering collaborative discussions among regulatory professionals worldwide.